Meet More Good Boys and Girls with OA
Fetch the Facts
Puppyhood came with instructions for everything — training hacks, teething toys, treats for “sit.” But once the shoes aren’t being chewed, the guidance quiets down. And we don’t always have a playbook for subtle behavior changes that could indicate something is wrong.
If your dog seems slower on walks or hesitant on stairs, it may be more than a sign of aging — it could be a common and painful disease called osteoarthritis (OA).1
When people hear “arthritis,” they might think it only impacts older dogs, but that’s not always the case. OA pain can affect dogs of all ages, breeds, and sizes.2 Good news: Treatment options are available, including veterinarian-administered solutions like LibrelaTM (bedinvetmab injection).† Think of this as your updated game plan.
OA is a degenerative joint disease that can cause dogs pain, stiffness and decreased mobility, and significantly impact their health and wellbeing.
Dogs often adapt to discomfort rather than show it, which can make the signs of OA easy to miss. But recognizing these changes early can make a meaningful difference.
Studies show that 40% of dogs live with signs of OA pain, making OA one of the most common causes of chronic canine pain.3
Kickoff: Understanding OA
Sideline Report: Real Stories from Pet Parents
Tap to reveal the subtle changes they noticed.
was struggling to keep
up on walks…
HAN SOLO
had difficulty standing up…
TAFFY
experienced stiffness, especially after lying down for a while…
NORMAN
had trouble going down the stairs...
TANK
Success Stories:
Winning Play:
Taking the Next Step
Pep Talk:
Questions to Ask Your Vet
Librela is a once-monthly injection given in the veterinarian’s office that’s designed to control OA pain in dogs.By targeting OA pain at its source, Librela helps support improved mobility and comfort so dogs can stay engaged in the everyday moments they love, like going for walks, playing fetch, or curling up comfortably at home.4,5
Before your next appointment, take this OA pain quiz and record a video to show your vet so they can better understand what your dog may be experiencing. Then bring these questions with you:
Could OA pain be affecting my dog?
What treatment options are available?
What results can I expect over time?
Is Librela an appropriate treatment option for my dog?
When it comes to your dog’s care, creating your game plan early changes everything.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. © 2026 Zoetis Services LLC. All rights reserved. LIB-00920
†IMPORTANT SAFETY INFORMATION: See full Prescribing Information at LibrelaPI.com. Librela is for use in dogs only. Women who are pregnant, trying to conceive or breastfeeding should take extreme care to avoid self-injection. Hypersensitivity reactions, including anaphylaxis, could potentially occur with self-injection. Librela should not be used in breeding, pregnant, or lactating dogs. Librela should not be administered to dogs with known hypersensitivity to bedinvetmab. Adverse events reported post-approval include ataxia (lack of balance/coordination), anorexia (loss of appetite), lethargy (tiredness), emesis (vomiting), and polydipsia (increased drinking). The most common adverse events reported in a clinical study were urinary tract infections, bacterial skin infections and dermatitis (skin irritation/inflammation).INDICATIONS: For the control of pain associated with osteoarthritis in dogs. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional.References:1 Lascelles BDX, Brown DC, Conzemius MG, Gill M, Oshinsky ML, Sharkey M. Measurement of chronic pain in companion animals: discussions from the Pain in Animals Workshop (PAW) 2017. Vet J. 2019;250:71-78. doi:10.1016/j. tvjl.2019.07.001.2 Anderson KL, Zulch H, O’Neill DG, Meeson RL, Collins LM. Risk factors for canine osteoarthritis and its predisposing arthropathies: a systematic review. Front Vet Sci. 2020;7:200. doi:10.3389/fvets.2020.002203 Wright A, et al. Identification of canine osteoarthritis using an owner-reported questionnaire and treatment monitoring using functional mobility tests. J Small Anim Pract, 2022. http://doi.org/10.1111/jsap.135004 Corral MJ, et al. A Prospective, Randomized, Blinded, Placebo-Controlled Multisite Clinical Study of Bedinvetmab, a Canine Monoclonal Antibody Targeting Nerve Growth Factor, in Dogs with Osteoarthritis. Vet Anaesth Analg. 2021;48:943-955.5 Michels GM, Honsberger NA, Walters RR, et al. A prospective, Randomized, Double-Blind, Placebo-Controlled, Multisite, Parallel-Group Field Study in Dogs with Osteoarthritis Conducted in the United States of America Evaluating Bedinvetmab, a Canine Anti-Nerve Growth Factor Monoclonal Antibody. Vet Anaesth Analg. 2023;50(5):446-458
…something many pet parents don’t immediately associate with joint pain.
Taffy
….a change his pet parent later learned could be linked to OA pain.
Han Solo
…a symptom commonly associated with OA pain.
Norman
….a subtle shift
that may signal
joint discomfort.
Tank